600012:SSEAnhui Expressway Company Limited Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥15.39
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading just above its 20‑day SMA and slightly below the 200‑day SMA, indicating a neutral price trend. Technical momentum is bullish, with a positive MACD histogram and an RSI sitting in the upper range, suggesting continued short‑term strength. At the same time, the trailing P/E is well below the industry average, pointing to relative cheapness on a valuation basis, while the dividend yield sits near four percent with a payout ratio under sixty percent, making the income profile attractive. However, the DCF‑derived fair value is substantially lower than the current market price, flagging a potential overvaluation from an intrinsic‑value perspective.
On the fundamentals side, revenue has contracted sharply and free cash flow is negative, raising concerns about cash generation. The balance sheet is heavily leveraged, with a debt‑to‑equity ratio that is extremely high, and this debt burden is a key source of financial risk. Combined with modest growth prospects and questions around dividend sustainability, the overall outlook leans toward caution despite the appealing yield.
On the fundamentals side, revenue has contracted sharply and free cash flow is negative, raising concerns about cash generation. The balance sheet is heavily leveraged, with a debt‑to‑equity ratio that is extremely high, and this debt burden is a key source of financial risk. Combined with modest growth prospects and questions around dividend sustainability, the overall outlook leans toward caution despite the appealing yield.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD and high RSI suggest short‑term upside
- Current price exceeds DCF fair value
- High dividend yield but sustainability concerns
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Negative revenue growth and free cash flow
- Extremely high debt‑to‑equity ratio
- Potential overvaluation relative to intrinsic value
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- Sustained leverage pressure on balance sheet
- Uncertain cash generation ability
- Dividend may not be maintainable in the long run
Key Metrics & Analysis
Financial Health
Revenue Growth-23.50%
Profit Margin25.01%
P/E Ratio14.8
ROE12.53%
ROA5.76%
Debt/Equity95.81
P/B Ratio2.1
Op. Cash FlowCN¥2.7B
Free Cash FlowCN¥-1342872320
Industry P/E29.3
Technical Analysis
TrendNeutral
RSI68.7
SupportCN¥13.77
ResistanceCN¥15.45
MA 20CN¥14.47
MA 50CN¥14.46
MA 200CN¥15.38
MACDBullish
VolumeStable
Fear & Greed Index79.45
Valuation
Fair ValueCN¥10.10
GradeOvervalued
TypeValue
Dividend Yield3.92%
Risk Assessment
Beta0.01
Volatility20.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.